Your browser doesn't support javascript.
loading
Specificity of NS1-based immunochromatographic tests for dengue virus with regard to the Zika virus protein.
Andreata-Santos, Robert; Pereira, Samuel Santos; Pereira, Lennon Ramos; Félix, Alvina Clara; Romano, Camila Malta; Ferreira, Luís Carlos de Souza.
Afiliação
  • Andreata-Santos R; Vaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Pereira SS; Vaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Pereira LR; Vaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Félix AC; Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo, Brazil.
  • Romano CM; Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo, Brazil; Hospital das Clinicas HCFMUSP (LIM52), Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
  • Ferreira LCS; Vaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Electronic address: lcsf@usp.br.
Int J Infect Dis ; 95: 276-278, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32289563
ABSTRACT

OBJECTIVES:

This study was performed to determine whether Dengue virus (DENV) immunochromatographic tests can detect and differentiate nonstructural protein 1 (NS1) from each of the four DENV serotypes and do not cross-react with the Zika virus (ZIKV) NS1 protein.

METHODS:

We compared the specificity of six NS1-based DENV immunochromatographic tests (point of care) in the detection of NS1 proteins from each of the four DENV serotypes and ZIKV. The tests were performed with NS1 proteins produced in mammalian cells. Cross-reactivity was confirmed with a purified recombinant ZIKV NS1 protein and DENV+ or ZIKV+ human serum samples.

RESULTS:

Cross-reaction was observed in 2 out of the 6 evaluated tests using cell culture supernatants containing NS1 protein of each tested virus. Cross-reactivity with ZIKV was confirmed with purified recombinant ZIKV NS1 produced in Escherichia coli. Further analyses with serum samples collected from DENV+ or ZIKV+ patients confirmed the cross-reactivity with ZIKV protein in 2 tests.

CONCLUSIONS:

The detection of the NS1 protein is the basis for several commercially available serological DENV diagnostic tests. The present results emphasize the relevance of testing specificity of presently available NS1-based DENV serological tests and the need of adjustments of tests that cross-react with the ZIKV protein. Our results are particularly relevant for regions where both viruses are endemically found, as in the case of Brazil.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromatografia de Afinidade / Proteínas não Estruturais Virais / Dengue / Vírus da Dengue / Zika virus Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromatografia de Afinidade / Proteínas não Estruturais Virais / Dengue / Vírus da Dengue / Zika virus Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2020 Tipo de documento: Article